Dutch randomized trial comparing standard catheter-directed thrombolysis versus Ultrasound-accElerated Thrombolysis for thromboembolic infrainguinal disease (DUET): design and rationale
2011

Comparing Standard and Ultrasound-Accelerated Thrombolysis for Thromboembolic Disease

Sample size: 60 publication Evidence: moderate

Author Information

Author(s): Schrijver A Marjolein, Reijnen Michel MPJ, van Oostayen Jacques A, Nolthenius Rudolf PJ Tutein, van der Valk Pieter HM, Hoksbergen Arjan WJ, Lely Rutger J, Fioole Bram, Vroegindeweij Dammis, van Leersum Marc, de Vries Jean-Paul PM

Primary Institution: St. Antonius Hospital Nieuwegein

Hypothesis

US-accelerated thrombolysis will result in a significant reduction in thrombolysis time (12 hours or more), without increasing the complication rate.

Conclusion

The DUET study aims to determine if US-accelerated thrombolysis can significantly reduce therapy time compared to standard thrombolysis without increasing complications.

Supporting Evidence

  • Thrombolytic therapy has increased over the years but is limited by bleeding complications.
  • Low-intensity ultrasound can accelerate thrombolysis and reduce therapy time.
  • Previous studies showed high technical success rates with ultrasound-accelerated thrombolysis.

Takeaway

This study is trying to find out if a new way of breaking up blood clots can work faster and safer than the old way.

Methodology

A multicenter, 2-group parallel randomized trial involving 60 adult patients with recently thrombosed infrainguinal arteries or bypass grafts.

Limitations

The study excludes patients with certain types of artery thrombosis and those with acute limb ischemia class IIb and III.

Participant Demographics

Adults aged 18 to 85 with acute lower limb ischemia due to thrombosed infrainguinal arteries or bypass grafts.

Digital Object Identifier (DOI)

10.1186/1745-6215-12-20

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication